Literature DB >> 7991585

Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells.

J R Müller1, M Potter, S Janz.   

Abstract

The translocation of c-myc on chromosome (chr.) 15 to an immunoglobulin heavy-chain switch region on chr. 12 is the critical oncogenic step in pristane-induced plasmacytoma (PCT) development in BALB/cAnPt mice. Applying a recently developed PCR method, we have been able to detect the most commonly occurring illegitimate recombinations between alpha-chain switch region (S alpha) and c-myc in preneoplastic B cells residing in mesenteric oil granuloma (OG) tissues 7-30 days postpristane. In this study, we compare the nucleotide sequences at the S alpha/c-myc breaksites on both the c-myc-activating chr. 12+ and the reciprocal chr. 15- from eight transplanted PCTs, seven primary PCTs, and five OGs that contained six B-cell clones. These junction sequences revealed a remarkable diversity of S alpha/c-myc recombinations. In nine cases--four PCTs and five B-cell clones--nearly precise reciprocal exchanges with a loss of only 3-35 bp in c-myc were found. Large deletions in c-myc that removed 369-878 bp were observed in seven PCTs but not in early B cells. Duplications of c-myc ranging from 103 to 229 bp were also restricted to PCTs and noticed in four cases. Clonally related but different reciprocal recombinations, 38 bp apart on chr. 12+ and 15 bp apart on chr. 15-, were isolated from two different specimens of the same OG tissue from a BALB/c mouse 30 days postpristane. A second OG from another 30-day mouse yielded four recombinational fragments--two clonally related chr. 12(+)-specific fragments and two chr. 15(-)-specific fragments--one of which carried a 143-bp insertion of a microsatellite at the breaksite. We suggest that the initial recombinational break-point regions between S alpha and c-myc in plasmacytoma precursor cells at the time of immunoglobulin heavy-chain switching are intrinsically labile and characterized by a persisting instability of c-myc, which can result in large secondary deletions of c-myc.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7991585      PMCID: PMC45377          DOI: 10.1073/pnas.91.25.12066

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Activation of cellular oncogenes in hemopoietic cells by chromosome translocation.

Authors:  S Cory
Journal:  Adv Cancer Res       Date:  1986       Impact factor: 6.242

2.  Products and implied mechanism of H chain switch recombination.

Authors:  J Petrini; W A Dunnick
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

3.  Mutations, duplication, and deletion of recombined switch regions suggest a role for DNA replication in the immunoglobulin heavy-chain switch.

Authors:  W Dunnick; M Wilson; J Stavnezer
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

4.  Looping out and deletion mechanism for the immunoglobulin heavy-chain class switch.

Authors:  H M Jäck; M McDowell; C M Steinberg; M Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas.

Authors:  G L Shen-Ong; E J Keath; S P Piccoli; M D Cole
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

6.  DNA damage induced by phorbol ester-stimulated neutrophils is augmented by extracellular cofactors. Role of histidine and metals.

Authors:  E Shacter; R L Lopez; E J Beecham; S Janz
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

7.  Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population.

Authors:  T J McDonnell; G Nunez; F M Platt; D Hockenberry; L London; J P McKearn; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

8.  Genes on chromosomes 1 and 4 in the mouse are associated with repair of radiation-induced chromatin damage.

Authors:  M Potter; K K Sanford; R Parshad; R E Tarone; F M Price; B Mock; K Huppi
Journal:  Genomics       Date:  1988-04       Impact factor: 5.736

9.  DNA repair defects associated with chromosomal translocation breaksite regions.

Authors:  E J Beecham; G M Jones; C Link; K Huppi; M Potter; J F Mushinski; V A Bohr
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

10.  Induction of immunoglobulin isotype switching in cultured I.29 B lymphoma cells. Characterization of the accompanying rearrangements of heavy chain genes.

Authors:  J Stavnezer; S Sirlin; J Abbott
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more
  6 in total

1.  IL-6 transgenic mouse model for extraosseous plasmacytoma.

Authors:  Alexander L Kovalchuk; Joong Su Kim; Sung Sup Park; Allen E Coleman; Jerrold M Ward; Herbert C Morse; Tadamitsu Kishimoto; Michael Potter; Siegfried Janz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  DNA sequence analysis of the genetic recombination between Igh6 and Myc in an uncommon BALB/c plasmacytoma, TEPC 1194.

Authors:  A L Kovalchuk; M Potter; S Janz
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

3.  Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.

Authors:  Y Shou; M L Martelli; A Gabrea; Y Qi; L A Brents; A Roschke; G Dewald; I R Kirsch; P L Bergsagel; W M Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Completion of the DNA sequence determination of the Igh2 locus of the mouse: the 5'-IA region.

Authors:  S Janz; V V Roschke
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  Burkitt lymphoma in the mouse.

Authors:  A L Kovalchuk; C F Qi; T A Torrey; L Taddesse-Heath; L Feigenbaum; S S Park; A Gerbitz; G Klobeck; K Hoertnagel; A Polack; G W Bornkamm; S Janz; H C Morse
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

Review 6.  Germline Risk Contribution to Genomic Instability in Multiple Myeloma.

Authors:  Siegfried Janz; Fenghuang Zhan; Fumou Sun; Yan Cheng; Michael Pisano; Ye Yang; Hartmut Goldschmidt; Parameswaran Hari
Journal:  Front Genet       Date:  2019-05-08       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.